NCT05228977 (CET) is a clinical trial in Prevalence of Cervical Extension of the Thymus, sponsored by Kabul University of Medical Sciences.

Who is sponsoring NCT05228977?

NCT05228977 is sponsored by Kabul University of Medical Sciences.

What condition does NCT05228977 study?

NCT05228977 studies Prevalence of Cervical Extension of the Thymus.

Is NCT05228977 still recruiting?

NCT05228977 is currently completed. Last updated 8 February 2022.

Last reviewed 2022-02-08 · How we verify

NCT05228977: CET

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prevalence of Cervical Extension of the Thymus in Children

Completed Last updated 8 February 2022

What this trial tests

trial in Prevalence of Cervical Extension of the Thymus in 220 participants. Completed in 30 October 2018.

Timeline

1 August 2018

Primary endpoint
1 October 2018

30 October 2018

Quick facts

Lead sponsor	Kabul University of Medical Sciences
Status	Completed
Study type	OBSERVATIONAL
Enrollment	220
Start date	1 August 2018
Primary completion	1 October 2018
Estimated completion	30 October 2018
Sites	2 locations across Afghanistan

Conditions studied

Prevalence of Cervical Extension of the Thymus — all drugs for Prevalence of Cervical Extension of the Thymus →

Sponsor

Kabul University of Medical Sciences

Who can join

Eligibility, any sex, with Prevalence of Cervical Extension of the Thymus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective, observational study included all pediatric patients who were referred to the radiology department for neck ultrasonography between August-October 2018. A high-frequency probe was implemented and 220 patients were examined.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Kabul University of Medical Sciences trials

Trials by the same sponsor.

NCT05266885 — Prevalence of Hypertension in Type-2 Diabetes Mellitus · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05228977 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kabul University of Medical Sciences
Last refreshed: 8 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05228977.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing